Teva Pharmaceutical Industries (NYSE:TEVA) said its “Pivot to Growth” strategy has moved into its second phase, with ...
New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as well as oral ...
Teva Pharmaceutical Industries Ltd. TEVA had a busy week that included a major debt refinancing, a milestone shift in how its ...
In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half of participants receiving TEV-'749 achieved ...
Teva Begins Trading Ordinary Shares Directly on the NYSE Teva Pharmaceutical Industries Ltd Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy ...
Good results on Teva's lab-made antibody that blocks gluten damage raise hopes that a treatment for celiac disease may ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) presented post hoc data from the Phase 3 SOLARIS trial for its investigational drug TEV-'749, a once-monthly subcutaneous long-acting injectable ...
In a major victory for Israeli pharmaceutical company Teva Israel, the Delhi High Court has held that a ₹1,851 crore payment ...
The new Teva Trailpeak model from the brand's Bureau of Adventure highlights sandal insights in trail running shoe design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results